CAS 204656-20-2

(4S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-il)propanoyl]amino]propanoyl]amino]-5-hid...

Descripción:

La sustancia química con el nombre "(4S)-5-[[[5S)-5-[[[2S)-2-[[[2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-5-hid" y el número CAS "204656-20-2" es un péptido complejo con múltiples estereocentros, lo que indica que probablemente exhiba quiralidad, lo que puede influir en su actividad biológica e interacciones. Esta sustancia se caracteriza por una serie de residuos de aminoácidos, incluyendo imidazol, lo que sugiere roles potenciales en sistemas biológicos, posiblemente como molécula de señalización o en la catálisis enzimática. La presencia de múltiples grupos amino y funcionalidades de ácido carboxílico indica que puede tener una solubilidad significativa en disolventes polares y podría participar en varias reacciones bioquímicas. Su estructura intrincada también puede sugerir propiedades conformacionales específicas que son cruciales para su función en contextos biológicos. En general, este compuesto ejemplifica la complejidad que a menudo se encuentra en péptidos y proteínas biológicamente activos.

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

InChI: InChI=1/C172H265N43O51/c1-18-20-21-22-23-24-25-26-27-28-29-30-37-53-128(223)193-112(59-64-132(227)228)148(244)180-68-41-40-50-111(154(250)199-116(62-67-135(233)234)155(251)204-120(73-100-44-33-31-34-45-100)160(256)214-140(93(11)19-2)168(264)192-97(15)146(242)201-122(76-103-79-183-108-49-39-38-48-106(103)108)158(254)203-118(72-90(5)6)159(255)212-138(91(7)8)166(262)200-110(52-43-70-182-172(177)178)150(246)184-81-129(224)194-109(51-42-69-181-171(175)176)149(245)187-84-137(237)238)196-144(240)95(13)189-143(239)94(12)191-153(249)115(58-63-127(174)222)195-130(225)82-185-152(248)114(61-66-134(231)232)198-156(252)117(71-89(3)4)202-157(253)119(75-102-54-56-105(221)57-55-102)205-163(259)124(85-216)208-165(261)126(87-218)209-167(263)139(92(9)10)213-162(258)123(78-136(235)236)206-164(260)125(86-217)210-170(266)142(99(17)220)215-161(257)121(74-101-46-35-32-36-47-101)207-169(265)141(98(16)219)211-131(226)83-186-151(247)113(60-65-133(229)230)197-145(241)96(14)190-147(243)107(173)77-104-80-179-88-188-104/h31-36,38-39,44-49,54-57,79-80,88-99,107,109-126,138-142,183,216-221H,18-30,37,40-43,50-53,58-78,81-87,173H2,1-17H3,(H2,174,222)(H,179,188)(H,180,244)(H,184,246)(H,185,248)(H,186,247)(H,187,245)(H,189,239)(H,190,243)(H,191,249)(H,192,264)(H,193,223)(H,194,224)(H,195,225)(H,196,240)(H,197,241)(H,198,252)(H,199,250)(H,200,262)(H,201,242)(H,202,253)(H,203,254)(H,204,251)(H,205,259)(H,206,260)(H,207,265)(H,208,261)(H,209,263)(H,210,266)(H,211,226)(H,212,255)(H,213,258)(H,214,256)(H,215,257)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H4,175,176,181)(H4,177,178,182)/t93-,94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1

Sinónimos:

• Liraglutida [INN-Spanish]
• Liraglutide
• Liraglutidum [INN-Latin]
• Nn 2211
• Nn2211
• Unii-839I73S42A
• Liraglutide [usan:inn]
• Liroglutide
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
• Liraglutide /Liraglutide Acetate
• Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-
• HAEGTFTSDVSSYLEGQAAK [N-(1-oxohexadecyl)-L-γ-glutaMyl] EFI AWLVRGRG
• (Lys(g-Glu-palMitoyl)26,Arg34)-GLP-1 (7-37)
• Liraglutida
• Liraglutide, (Lys(γ-Glu-palmitoyl)26,Arg34)-GLP-1 (7-37)
• (Lys(γ-Glu-palMitoyl)26,Arg34)-GLP-1 (7-37)
• H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(g-Glu-palMitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
• Liraglutidum
• Liraglutide Impurity
• Liraglutide injection
• Liraglutide, NN2211
• NNC 90-1170
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
• Victoza

Liraglutide trifluoroacetate salt

CAS: 204656-20-2

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and used to treat diabetes mellitus type 2 and obesity. The GLP-1 receptor agonists stimulate insulin secretion and inhibit glucagon secretion.

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: 98.9%

Peso molecular: 3751.26

Ref: 01-4041752

Liraglutide

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: 99%

Forma y color: Solid

Peso molecular: 3751.2020

Ref: IN-DA003RAK

Liraglutide-d8 Tritrifluoroacetate

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₅₇D₈N₄₃O₅₁·3C₂HF₃O₂

Forma y color: White To Off-White Solid

Peso molecular: 3759.31 3*114.02

Ref: 4Z-PL-105002

Liraglutide-d8 Tetratrifluoroacetate

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₅₇D₈N₄₃O₅₁·4C₂HF₃O₂

Peso molecular: 3759.31 4*114.02

Ref: 4Z-PL-105047

Liraglutide

CAS: 204656-20-2

Liraglutide

Peso molecular: 3751g/mol

Ref: 54-BI9895

Liraglutide

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Forma y color: White To Off-White Solid

Peso molecular: 3751.26

Ref: 4Z-PL-105001

Liraglutide

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: 95%~99%

Forma y color: White to Off-white Powder

Peso molecular: 3751. 20

Ref: BP-BPPG046

Liraglutide

CAS: 204656-20-2

Liraglutide (Liraglutida) is a synthetic analog of GLP-1, an agonist of the GLP-1 receptor. Liraglutide is an antidiabetic agent. Cost effective and quality assured.

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: 97.65% - 99.04%

Forma y color: Solid

Peso molecular: 3751.25

Ref: TM-T6876

Liraglutide

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: ≥ 98.0%

Forma y color: White to off-white powder

Peso molecular: 3751.2

Ref: 7W-GX3695

Liraglutide

Producto controlado

CAS: 204656-20-2

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Forma y color: Off-White

Peso molecular: 3751.2

Ref: TR-L468860

Liraglutide sodium

CAS: 204656-20-2

Please enquire for more information about Liraglutide sodium  including the price, delivery time and more detailed product information at the technical inquiry form on this page

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁•(Na)x

Ref: 3D-BL184581

Liraglutide acetate

CAS: 204656-20-2

Liraglutide is a glucagon-like peptide-1 analog that has been shown to be an effective treatment for obesity. Liraglutide targets the adipose tissue and reduces the amount of glucose in the blood by increasing insulin sensitivity, lowering food intake, and reducing appetite. In addition, Liraglutide has been shown to suppress postprandial hyperglycemia and lower plasma glucose levels in patients with type 2 diabetes mellitus. Liraglutide also inhibits neuronal death induced by apoptotic stimuli, which may have potential use as a model system for neurodegenerative diseases such as Parkinson's disease. Liraglutide has also been shown to be an effective therapy for infectious diseases including Crohn's disease and ulcerative colitis. This drug has shown some effectiveness against atherosclerosis in animal models by inducing apoptosis in macrophages that are associated with lesions.

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: Min. 95%

Peso molecular: 3,751.29 g/mol

Ref: 3D-PGL-3781-PI

Liraglutide

CAS: 204656-20-2

Glucagon-like peptide 1 (GLP-1) receptor agonist; hypoglycemic agent

Fórmula: C₁₇₂H₂₆₅N₄₃O₅₁

Pureza: Min. 95 Area-%

Forma y color: White Powder

Peso molecular: 3,751.2 g/mol

Ref: 3D-FL109949